6.
Karrison T, Ferguson D, Meier P
. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999; 91(1):80-5.
DOI: 10.1093/jnci/91.1.80.
View
7.
Zhang X, Giuliano M, Trivedi M, Schiff R, Osborne C
. Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res. 2013; 19(23):6389-97.
PMC: 3878717.
DOI: 10.1158/1078-0432.CCR-13-0838.
View
8.
Colleoni M, Sun Z, Price K, Karlsson P, Forbes J, Thurlimann B
. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. J Clin Oncol. 2016; 34(9):927-35.
PMC: 4933127.
DOI: 10.1200/JCO.2015.62.3504.
View
9.
Kurbegovic S, Drimer Berg K, Thomsen F, Gruschy L, Iversen P, Brasso K
. The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy. Scand J Urol. 2017; 51(6):450-456.
DOI: 10.1080/21681805.2017.1356369.
View
10.
Weston W, Barr A
. A cell cycle centric view of tumour dormancy. Br J Cancer. 2023; 129(10):1535-1545.
PMC: 10645753.
DOI: 10.1038/s41416-023-02401-z.
View
11.
Arora M, Moser J, Phadke H, Basha A, Spencer S
. Endogenous Replication Stress in Mother Cells Leads to Quiescence of Daughter Cells. Cell Rep. 2017; 19(7):1351-1364.
PMC: 5533606.
DOI: 10.1016/j.celrep.2017.04.055.
View
12.
Yang H, Chung M, Kudo T, Meyer T
. Competing memories of mitogen and p53 signalling control cell-cycle entry. Nature. 2017; 549(7672):404-408.
PMC: 6544019.
DOI: 10.1038/nature23880.
View
13.
Yu-Lee L, Lee Y, Pan J, Lin S, Pan T, Yu G
. Bone secreted factors induce cellular quiescence in prostate cancer cells. Sci Rep. 2019; 9(1):18635.
PMC: 6901558.
DOI: 10.1038/s41598-019-54566-4.
View
14.
Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X
. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022; 7(1):3.
PMC: 8724284.
DOI: 10.1038/s41392-021-00762-6.
View
15.
Jonsson M, Dejmek J, Bendahl P, Andersson T
. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 2002; 62(2):409-16.
View
16.
Weber J, Calvi L
. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone. 2009; 46(2):281-5.
PMC: 3073451.
DOI: 10.1016/j.bone.2009.08.007.
View
17.
Rick J, Chandra A, Dalle Ore C, Nguyen A, Yagnik G, Aghi M
. Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications. Semin Oncol. 2019; 46(3):284-290.
PMC: 6801036.
DOI: 10.1053/j.seminoncol.2019.08.002.
View
18.
Ren D, Dai Y, Yang Q, Zhang X, Guo W, Ye L
. Wnt5a induces and maintains prostate cancer cells dormancy in bone. J Exp Med. 2018; 216(2):428-449.
PMC: 6363426.
DOI: 10.1084/jem.20180661.
View
19.
Ghajar C, Peinado H, Mori H, Matei I, Evason K, Brazier H
. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013; 15(7):807-17.
PMC: 3826912.
DOI: 10.1038/ncb2767.
View
20.
Catena R, Bhattacharya N, El Rayes T, Wang S, Choi H, Gao D
. Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. Cancer Discov. 2013; 3(5):578-89.
PMC: 3672408.
DOI: 10.1158/2159-8290.CD-12-0476.
View